Tropical Medicine Research Centers (TMRCs)

Phlebotomus papatasi sand fly, one of the species of sand flies responsible for the spread of the vector-borne parasitic disease Leishmaniasis.

Credit: CDC

NIAID awarded the Tropical Medicine Research Centers (TMRCs) in 1991 to establish international research sites in disease-endemic countries. The program was renewed in 2017, with the funding of seven Centers (five new Centers and two renewals). The Centers are designed to facilitate research on the cause, diagnosis, prevention, and treatment of NTDs, and to create and sustain in-country research capacity.

Main Areas of Focus

  • To conduct research on the neglected tropical diseases (NTDs) such as schistosomiasis, hookworm infection, ascariasis, leishmaniasis, Chagas' disease, lymphatic filariasis, and foodborne trematodiases, leishmaniasis, neurocysticercosis, and Chagas' disease
  • To support clinical and field site development
  • To build capacity to enable TMRCs to conduct future clinical trials, implement new treatment and prevention strategies, and develop novel vector control strategies

Oversight

  • Parasitology and International Programs Branch (PIPB), Division of Microbiology and Infectious Diseases (DMID)

Program Overview

NTDs, such as Chagas’ disease, leishmaniasis, and schistosomiasis, are a major problem in developing countries, where they contribute significantly to the overall burden of disease. In an effort to support tropical medicine research in endemic international areas and in populations most affected by these diseases, NIAID initiated the Tropical Medicine Research Centers (TMRC) program in 1991.


Read more about TMRCs

Locations

There are seven TMRCs worldwide that conduct clinical trials, implement new treatment and prevention strategies, and develop novel vector control strategies.


Sites and primary investigators
Content last reviewed on